Medcaw Investments Plc Share Price

Equities

MCI

GB00BM8SQP62

Investment Holding Companies

Market Closed - London S.E. 16:00:00 07/07/2023 BST 5-day change 1st Jan Change
4 GBX -.--% Intraday chart for Medcaw Investments Plc -.--% -.--%
Sales 2021 - Sales 2022 - Capitalization 1.8M 141M
Net income 2021 - 0 Net income 2022 - 0 EV / Sales 2021 * -
Net cash position 2021 200K 15.74M Net cash position 2022 644K 50.56M EV / Sales 2022 -
P/E ratio 2021 *
-
P/E ratio 2022
-5.54 x
Employees 3
Yield 2021 *
-
Yield 2022
-
Free-Float 25.48%
More Fundamentals * Assessed data
Dynamic Chart
1 year
3.50
Extreme 3.5
4.75
3 years
2.00
Extreme 2
10.50
5 years
2.00
Extreme 2
10.50
10 years
2.00
Extreme 2
10.50
More quotes
Members of the board TitleAgeSince
Chairman 61 02/03/23
Director/Board Member 49 02/03/23
Director/Board Member 52 -
More insiders
Medcaw Investments plc is a United Kingdom-based acquisition vehicle. The Company's objective is to identify and acquire prospective lithium mining projects across Africa. It has entered into a conditional implementation agreement with Abyssinian Metals Limited (AML), a company developing the Kenticha lithium project located in Oromia State, Southern Ethiopia. The Kenticha project (Kenticha) is a highly evolved, rare element, lithium caesium tantalum (LCT) pegmatite project comparable to other major rare-element pegmatites such as Greenbushes, Tanco, Wodgina, Volta Grande and Altai No.3. Kenticha is a late-stage development asset which AML intends to develop with the production of spodumene concentrate planned in stages, with near-term production through a dense medium separation (DMS) modular plant.
More about the company